![Peer-Spectives artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts125/v4/36/e6/62/36e6623f-f57c-fbd4-84fb-34267275b766/mza_11777352931460000686.jpg/100x100bb.jpg)
The Best First Step in Metastatic NSCLC Care
Peer-Spectives
English - March 10, 2023 20:24 - 9 minutes - 12.8 MBScience Education obr oncology cancer healthcare medical obroncology peerspectives robertfiglin Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Neo- and Adjuvant Treatments Are Changing Care in Early NSCLC
With more than 10 known driver mutations in non-small cell lung cancer (NSCLC), testing is ever more critical, says Heather Wakelee, MD, division chief of medical oncology at Stanford University and president of the International Association for the Study of Lung Cancer. Listen as she and Peer-Spectives host Bob Figlin, MD, the Steven Spielberg Family Chair in Hematology Oncology at Cedars-Sinai Cancer, talk about how she manages patients with metastatic disease or those who need adjuvant treatment, when she starts targeted therapy or immunotherapy, and more. “We can drastically change the course of disease for a patient by giving them the appropriate targeted treatment. So that testing is so critical,” Dr. Wakelee said.